Skip to content

  ( )

ChemoTech
When life science matters
ChemoTechChemoTech
+46 (0)10 218 93 00[email protected]
Facebook page opens in new windowTwitter page opens in new windowYouTube page opens in new windowLinkedin page opens in new window
  • About ChemoTech
    • About ChemoTech
    • Company Management
    • Events
    • Career
  • Our Products
  • Publications
    • ChemoTech Publications
    • General Publications
    • Clinical Guidelines
  • News & Press Releases
    • Svenska
    • English
  • Investors
    • Investor Relations
    • IPO/Share Issue Documents
    • Financial Reports
    • Financial Analysis
    • Financial Calendar
    • Shareholders Meeting
    • Presentations
    • Rights Issue – Företrädesemission 2022
  • Contact
  • Vetiqure
  • About ChemoTech
    • About ChemoTech
    • Company Management
    • Events
    • Career
  • Our Products
  • Publications
    • ChemoTech Publications
    • General Publications
    • Clinical Guidelines
  • News & Press Releases
    • Svenska
    • English
  • Investors
    • Investor Relations
    • IPO/Share Issue Documents
    • Financial Reports
    • Financial Analysis
    • Financial Calendar
    • Shareholders Meeting
    • Presentations
    • Rights Issue – Företrädesemission 2022
  • Contact
  • Vetiqure

IPO/Share Issue Documents

You are here:
  1. Home
  2. Investor Relations
  3. IPO/Share Issue Documents

IPO/Share Issue Documents

2022

Villkor för teckningsoptioner serie TO3A avseende nyteckning av aktier i Scandinavian ChemoTech

2022

Villkor för teckningsoptioner serie TO3B avseende nyteckning av aktier i Scandinavian ChemoTech

2022

Tilläggsprospekt – Scandinavian ChemoTech AB

2022

EU-tillväxtprospekt – Scandinavian ChemoTech

2021

Anmälningssedel för teckning av aktier med stöd av teckningsoptioner av serie TO1 och TO2

2020

Investeringsmemorandum ChemoTech 2020

2020

Anmälningssedel teckning av B-units utan stöd av uniträtter-B

2020

Anmälningssedel teckning av B-units med stöd av uniträtter-B

2018

Inbjudan till teckning av aktier

2016

ChemoTech Bolagsbeskrivning

Investor Relations
  • Investor Relations
  • IPO/Share Issue Documents
  • Financial Reports
  • Financial Analysis
  • Financial Calendar
  • Presentations
CONTACT US
  • Location:
    Scandinavian ChemoTech AB, Medicon Village, Scheeletorget 1, SE-223 63 Lund, Sweden
  • Phone numbers:
    +46 (0)10 218 93 00
  • E-mail:
    [email protected]

Find us on:

Facebook page opens in new windowTwitter page opens in new windowYouTube page opens in new windowLinkedin page opens in new window
Go to Top